drugset / Trial / NCT01271686
24-hour IOP-lowering Effect of 0.01% Bimatoprost
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the 24-hour IOP-lowering efficacy of 0.01% bimatoprost once daily in patients with glaucoma or ocular hypertension
Timeline
- Start
- 2011-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.01 % | — |